Company / Goodwill
Caris Life Sciences, Inc. Goodwill History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$19.3M
FY2025
5-year range
$19.3M / $19.3M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#122 of 136
Health Care
What the data says
Among 136 Health Care companies, Caris Life Sciences, Inc. is in the bottom 10% for goodwill.
Based on SEC 10-K filings.
$19M in FY2025.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 136This company $19.3M Sector average $5.2B
▼
-99.6% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.3M | - |
| FY2024 | - | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026